← Nutex Health Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $0 $23k $60k $1.4m $1.6m $18.8m $219.3m $247.6m $479.9m $875.3m
Cost of Goods and Services Sold — $14k $31k $830k $910k $14.6m $135.9m $153.4m $307.3m $548.0m
Gross Profit $0 ($7k) $29k $536k $676k $4.1m $13.5m $34.8m $196.3m $444.3m
Operating Expenses — $5.7m $1.9m $7.4m $5.9m $13.2m $420.1m $66.5m $65.6m $168.7m
Operating Income (Loss) ($449k) ($5.7m) ($1.8m) ($6.9m) ($5.2m) ($9.0m) ($406.6m) ($31.8m) $130.7m $275.6m
Additional Financial Items
Amortization of Intangible Assets — — $534k $118k $59k — $1.2m $1.6m $1.5m $1.3m
Goodwill, Impairment Loss — — — — $3.5m $0 $398.1m — $3.2m $0
Income (Loss) from Continuing Operations, Per Basic Share ($0) ($0) ($0) ($2) $0 $0 ($1) ($0) $10 $11
Interest Income, Other — $0 — — — — — — — —
Investment Income, Interest — — — $4k $1k $917 — — — —
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest — — — $7.1m ($5.7m) ($14.7m) ($419.6m) ($48.5m) $109.8m $244.8m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($451k) ($6.0m) ($2.8m) $7.1m $5.7m $13.7m $424.8m $45.8m $52.2m $70.8m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest — — — — ($5.5m) $13.7m $8.0m $2.4m $43.1m —
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($7.0m) $6.6m $0 — $119k $0 $8.0m $2.4m $43.1m $109.6m
Net Income (Loss) Attributable to Parent ($7.4m) $582k ($2.8m) ($7.1m) ($5.7m) ($13.7m) ($424.8m) ($45.8m) $52.1m $70.8m
Net Income (Loss) Available to Common Stockholders, Basic ($7.4m) $582k ($950k) ($7.1m) $0 $13.7m ($1) ($0) $52.1m $70.8m
Net Income (Loss) Attributable to Noncontrolling Interest — — — — $0 $891 ($8.0m) $2.4m $42.7m $109.6m
Earnings Per Share, Basic ($0.19) $0.01 ($0.56) ($1.96) $0.18 $0.22 ($0.67) ($0.07) $10.23 $11.13
Earnings Per Share, Diluted ($0.19) — — — $0.18 $0.22 ($0.67) ($0.07) $9.69 $10.48
Weighted Average Number of Shares Outstanding, Basic — — — — — — 634.9m 661.2m 5.1m 6.4m
Weighted Average Number of Shares Outstanding, Diluted 39.7m — — — — — — — 5.5m 6.8m
Other Nonoperating Income (Expense) — ($315k) ($984k) ($219k) ($502k) ($5.6m) ($559k) ($399k) $669k ($8.6m)
Interest Expense (non-operating) — — — — — — — — $19.9m $22.2m
Business Combination, Acquisition Related Costs — — — — — — $3.9m $43k $0 $0
Costs and Expenses — — — — — — $205.8m $212.9m $283.7m $431.0m
Current Income Tax Expense (Benefit) — — — — $0 $0 $13.1m $5.1m $14.5m $64.4m
General and Administrative Expense $449k $1.8m $1.2m $3.7m $3.3m $12.2m $18.0m $33.2m $41.9m $51.7m
Interest Expense ($3k) $367k $642k $92k $335k — $12.5m $16.3m — —
Interest Expense, Debt — $339k $631k $631k $335k — — — — —
Labor and Related Expense — — — — — — — $108.4m $117.5m $158.1m
Marketing and Advertising Expense — — — — — — — — — $6.5m
Nonoperating Income (Expense) ($2k) — — — — — — — — —
Other Cost and Expense, Operating — — — — — — — — $49.0m —
Other Expenses — — — — — — $30.4m $30.4m $31.1m $44.8m
Research and Development Expense — — — $768k $557k $286k — — — —
Selling and Marketing Expense — — — $578k $167k — — — — —
Income Tax Expense (Benefit) — — — $0 $0 ($985k) $13.1m ($5.1m) $15.0m $64.4m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.